Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 2, 2021
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
Andrew Berens Maintained (AZN) at Buy with Decreased Target to $63 on, Mar 2nd, 2021
Andrew Berens of SVB Leerink, Maintained "AstraZeneca PLC" (AZN) at Buy with Decreased Target from $64 to $63 on, Mar 2nd, 2021.
Andrew has made no other calls on AZN in the last 4 months.
There are 2 other peers that have a rating on AZN. Out of the 2 peers that are also analyzing AZN, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Michael Leuchten of "UBS" Upgraded from Hold to Strong Buy on, Thursday, February 25th, 2021
- Emmanuel Papadakis of "Deutsche Bank" Initiated at Strong Buy on, Friday, January 15th, 2021
